Skip to main content

Table 2 The list of potential side effects

From: Does intervention with GLP-1 receptor agonist semaglutide modulate perception of sweet taste in women with obesity: study protocol of a randomized, single-blinded, placebo-controlled clinical trial

Nervous system disorders

Dizziness

Dysgeusia

Cardiac disorders

Increased heart rate

Gastrointestinal disorders

Nausea

Diarrhoea

Vomiting

Abdominal pain

Abdominal distension

Constipation

Dyspepsia

Gastritis

Gastro-oesophagealreflux diseaseafe

Eructation

Flatulence

Acute pancreatitis

Hepatobiliary disorders

Cholelithiasis

General disorders and administration site conditions

Fatigue

Injection site reactions